Hemant Surgical — 360° view

Hemant Surgical, a company in the Medical Equipment & Supplies industry, reported revenue of ₹276 crore and net profit of ₹19 crore for the September 2026 quarter.

Hemant Surgical (BSE: HSIL) closed at ₹580.25 on 20 Nov 2026, up 103.6% over the past year. Its market capitalisation is ₹844 crore and it trades at 48.3 times earnings.

Share price
₹580.25 (20 Nov 2026)
Market cap
₹844 Cr (20 Nov 2026)
P/E
48.34 (20 Nov 2026)
Revenue
₹276 Cr (September 2026 quarter)
Net profit
₹19 Cr (September 2026 quarter)
ROCE
18.9% (FY26)
ROE
17.4% (FY26)
Book value
₹123 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹679.00 / ₹215.00 (20 Nov 2026)
1-year return
103.6% (to 20 Nov 2026)
Sector
Healthcare
Industry
Medical Equipment & Supplies
Symbol
BSE: HSIL

Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.